Quantitative Systematic Strategies LLC Reata Pharmaceuticals Inc Transaction History

Quantitative Systematic Strategies LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 16, 2021	SELL	$100.0 - $143.02 $203,100 - $290,473	-2,031 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$78.27 - $151.29 $260,560 - $503,644	-3,329 Reduced 62.11%	2,031 $287,000
Q1 2021 May 06, 2021	SELL	$94.25 - $132.81 $62,205 - $87,654	-660 Reduced 10.96%	5,360 $534,000
Q4 2020 Feb 09, 2021	BUY	$102.03 - $184.62 $126,007 - $228,005	1,235 Added 25.81%	6,020 $744,000
Q3 2020 Nov 09, 2020	BUY	$93.53 - $163.34 $266,841 - $466,009	2,853 Added 147.67%	4,785 $466,000
Q2 2020 Aug 04, 2020	BUY	$126.3 - $176.56 $244,011 - $341,113	1,932 New	1,932 $301,000
Q1 2020 May 06, 2020	SELL	$124.16 - $247.74 $355,842 - $710,022	-2,866 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$74.57 - $217.92 $213,717 - $624,558	2,866 New	2,866 $586,000

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.